Welcome to our monthly enewsletter, CDI Notebook, focused on keeping you abreast of the latest innovations using CDI’s iCell® and MyCell® products.
In this issue:
Now Available! iCell Cardiac Progenitor Cells. These dynamic human iPS cell-derived progenitors are able to differentiate into terminally derived cardiac cell types. Thus, they provide a relevant substrate for basic biology research, drug discovery screens, and method development in which progenitors can be used as a regenerative medicine therapeutic.
Dr. Bill Murphy, UW-Madison, Discusses the Advantages of iPS Cell-derived Human Cells for Tissue Generation. Hear Dr. Murphy’s perspective on the use of iCell Endothelial Cells in the development of in vitro models for human vascularization and how this capability could enable personalized medicine.
Pharmacological Characterisation of Ligand- and Voltage-gated Ion Channels Expressed in Human iPSC-derived Forebrain Neurons. Read about gene expression profiling and functional studies of iCell Neurons demonstrating they are a pertinent cellular model to study the molecular mechanisms of autism spectral disorders and other neurological diseases.
Dage JL, Colvin EM, et al. (2014) Psychopharmacology.
Long-term Electrophysiological Activity and Pharmacological Response of a Human Induced Pluripotent Stem Cell-derived Neuron and Astrocyte Co-culture. Learn how the use of iCell Neurons and rat primary astrocyte co-cultures on a multielectrode array is an effective method to study the electrical activity of neurons.
Odawara A, Saitoh Y, et al. (2014) Biochemical and Biophysical Research Communications.
Parkinson’s Disease: Genetics, Mechanisms and Therapeutics
Alzheimer’s Disease – From Fundamental Insights to Light at the End of
the Translational Tunnel
(Mar 2 – 7 | Keystone, CO). Visit our poster and learn how iCell products can advance
your neuroscience research during these Keystone symposia.
Society of Toxicology 2014 (Mar 23 – 27 | Phoenix, AZ | Booth 518). Start planning your SOT 2014 itinerary today by noting these sessions in your calendar:
- Induced Human Pluripotent Stem Cells and Their Differentiated Progeny Cells: Implementation in Toxicity Testing Stem Cell Models for Integrated Biology (Mar 24 |
9:15 am – 12:00 pm)
- Beyond hERG: Novel Cardiovascular De-risking Strategies and Their Regulatory Acceptance (Mar 26 | 1:30 – 4:15 pm)
The following posters presented at SLAS2014 are accessible online: